Tag - OPS

Developments

Opsens gets FDA clearance to market diastolic pressure algorithm

Opsens (TSX:OPS; OTCQX:OPSSF) received 510(k) clearance from the FDA to market its diastolic pressure ratio (dPR) algorithm. The algorithm is designed to be used with Opsens’ OptoWire, a coronary guide wire used for...

December 19, 2019

Developments

Opsens in first clinical use of OptoWire III after Health Canada approval

Opsens (TSX:OPS; OTCQX:OPSSF) announced the world’s first clinical use of its OptoWire III at the Quebec Heart and Lung Institute, following Health Canada’s recent approval of the device. OptoWire III is a...

November 7, 2019

Tag - OPS

Opsens gets FDA clearance to market diastolic pressure algorithm

Opsens in first clinical use of OptoWire III after Health Canada approval

General

More